Search results for CDKN2A

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody, Abbexa, abx037357

Rabbit Polyclonal against the CDKN2A protein.

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody, Abbexa, abx422688

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody is a Mouse monoclonal against Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A).

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody, Abbexa, abx125659

CDKN2A Antibody is a Rabbit Polyclonal against CDKN2A.

Mouse CDKN2A Interacting Protein (CDKN2AIP) ELISA Kit, Abbexa, abx388823

Mouse CDKN2A Interacting Protein (CDKN2AIP) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Mouse CDKN2AIP concentrations in tissue homogenates, cell lysates and other biological fluids.

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody, Abbexa, abx422687

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody is a Mouse monoclonal against Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A).

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody, Abbexa, abx171984

This product is currently in development. The lead time for this product may be several months. Please contact us at [email protected] for an updated lead time before purchasing this product. Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody is a Mouse Monoclonal antibody against Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A).

Anti-CDKN2A/p14ARF antibody [ARF 4C6/4], Abcam, AB11048

Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal, Abcam, AB108349

Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), IHC-P, IP and WB. Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) was first used in a scientific publication in 2013 and has been cited over 192 times in peer reviewed journals. It's performance in Western Blot and IHC in human samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) has been confirmed by Western Blot testing in CDKN2A/p16INK4a knockout HEK-293T cells. Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) has 6 independent reviews from customers. Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) specifically detects CDKN2A/p16INK4a (UniProt ID: P42771; Molecular weight: 17kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EPR1473 - ab186932 . Antibody clone EPR1473 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 647, PE ( ab192054 , ab209579 ). CDKN2A, encoding the tumor suppressor protein p16INK4a, plays a crucial role in regulating the cell cycle by inhibiting cyclin-dependent kinases, thereby preventing uncontrolled cell proliferation. Mutations or deletions in CDKN2A are frequently associated with various cancers, including melanoma, pancreatic cancer and head and neck squamous cell carcinoma. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CDKN2A/p16INK4A + CDKN2B/p15INK4B antibody [EP435Y], Abcam, AB40803

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody, Abbexa, abx422685

Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) Antibody is a Mouse monoclonal against Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A).